Cargando…

A novel chemokine‐based signature for prediction of prognosis and therapeutic response in glioma

AIMS: Gliomas are the primary malignant brain tumor and characterized as the striking cellular heterogeneity and intricate tumor microenvironment (TME), where chemokines regulate immune cell trafficking by shaping local networks. This study aimed to construct a chemokine‐based gene signature to eval...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fan, Wenhua, Wang, Di, Li, Guanzhang, Xu, Jianbao, Ren, Changyuan, Sun, Zhiyan, Wang, Zhiliang, Ma, Wenping, Zhao, Zheng, Bao, Zhaoshi, Jiang, Tao, Zhang, Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627384/ https://www.ncbi.nlm.nih.gov/pubmed/35985661 http://dx.doi.org/10.1111/cns.13944

Ejemplares similares

LRRFIP1, an epigenetically regulated gene, is a prognostic biomarker and predicts malignant phenotypes of glioma
por: Ma, Wenping, et al.
Publicado: (2022)

Comprehensive transcriptomic characterization reveals core genes and module associated with immunological changes via 1619 samples of brain glioma
por: Zhang, Ying, et al.
Publicado: (2021)

Identification of IDH-mutant gliomas by a prognostic signature according to gene expression profiling
por: Wang, Qiangwei, et al.
Publicado: (2018)

Identification of an ATP metabolism‐related signature associated with prognosis and immune microenvironment in gliomas
por: Huang, Ruoyu, et al.
Publicado: (2020)

MEGF10, a Glioma Survival-Associated Molecular Signature, Predicts IDH Mutation Status
por: Li, Guanzhang, et al.
Publicado: (2018)

Chinese Glioma Genome Atlas (CGGA): A Comprehensive Resource with Functional Genomic Data from Chinese Glioma Patients
por: Zhao, Zheng, et al.
Publicado: (2021)

WES data from 286 diffuse gliomas under the 2021 WHO Classification of Tumors of the Central Nervous System
por: Zhao, Zheng, et al.
Publicado: (2022)

SAMD9 Is Relating With M2 Macrophage and Remarkable Malignancy Characters in Low-Grade Glioma
por: Ma, Wenping, et al.
Publicado: (2021)

MicroRNA expression patterns in the malignant progression of gliomas and a 5-microRNA signature for prognosis
por: Yan, Wei, et al.
Publicado: (2014)

Comprehensive Analysis of the Clinical and Biological Significances of Endoplasmic Reticulum Stress in Diffuse Gliomas
por: Huang, Ruoyu, et al.
Publicado: (2021)

A novel methylation signature predicts radiotherapy sensitivity in glioma
por: Feng, Yuemei, et al.
Publicado: (2020)

Corrigendum: Comprehensive analysis of the clinical and biological significances of endoplasmic reticulum stress in diffuse gliomas
por: Huang, Ruoyu, et al.
Publicado: (2022)

A Novel TNFSF-Based Signature Predicts the Prognosis and Immunosuppressive Status of Lower-Grade Glioma
por: Tao, Rui, et al.
Publicado: (2022)

Clinical characterization and immunosuppressive regulation of CD161 (KLRB1) in glioma through 916 samples
por: Di, Wang, et al.
Publicado: (2021)

TREM2 is associated with tumor immunity and implies poor prognosis in glioma
por: Yu, Mingchen, et al.
Publicado: (2023)

Functional clustering analysis identifies specific subtypes of aldehyde dehydrogenase associated with glioma immunity
por: Wang, Di, et al.
Publicado: (2021)

A novel gene signature based on five immune checkpoint genes predicts the survival of glioma
por: Zhang, Wei, et al.
Publicado: (2021)

NK Cell-Based Immunotherapy and Therapeutic Perspective in Gliomas
por: Pan, Changqing, et al.
Publicado: (2021)

Molecular Characterization and Clinical Relevance of ANXA1 in Gliomas via 1,018 Chinese Cohort Patients
por: Qian, Zenghui, et al.
Publicado: (2021)

Comparative profiling of immune genes improves the prognoses of lower grade gliomas
por: Wang, Zhiliang, et al.
Publicado: (2022)

A novel 7-chemokine-genes predictive signature for prognosis and therapeutic response in renal clear cell carcinoma
por: Lin, Ming-Jie, et al.
Publicado: (2023)

Stalled oligodendrocyte differentiation in IDH-mutant gliomas
por: Wei, Yanfei, et al.
Publicado: (2023)

BMP4, a strong better prognosis predictor, has a subtype preference and cell development association in gliomas
por: Bao, Zhaoshi, et al.
Publicado: (2013)

An MRI radiomics approach to predict survival and tumour-infiltrating macrophages in gliomas
por: Li, Guanzhang, et al.
Publicado: (2022)

IDH mutation-specific radiomic signature in lower-grade gliomas
por: Liu, Xing, et al.
Publicado: (2019)

Predicting the prognosis of glioma by pyroptosis‐related signature
por: Chao, Bo, et al.
Publicado: (2021)

A novel 25-ferroptosis-related gene signature for the prognosis of gliomas
por: Peng, Xiaojiang, et al.
Publicado: (2023)

Construction and validation of a chemokine family-based signature for the prediction of prognosis and therapeutic response in colon cancer
por: Zhang, Wen, et al.
Publicado: (2023)

A novel cuproptosis-related gene signature to predict prognosis in Glioma
por: Zhang, Mengyang, et al.
Publicado: (2023)

Galectin-9/TIM-3 as a Key Regulator of Immune Response in Gliomas With Chromosome 1p/19q Codeletion
por: Li, Guanzhang, et al.
Publicado: (2021)

CKAP2 expression is associated with glioma tumor growth and acts as a prognostic factor in high-grade glioma
por: Wang, Kuanyu, et al.
Publicado: (2018)

Ferroptosis-Related Gene Signature Predicts Glioma Cell Death and Glioma Patient Progression
por: Liu, Han-jie, et al.
Publicado: (2020)

Identification of a gene signature associated with radiotherapy and prognosis in gliomas
por: Li, Shu, et al.
Publicado: (2017)

Novel chemokine related LncRNA signature correlates with the prognosis, immune landscape, and therapeutic sensitivity of esophageal squamous cell cancer
por: Zhang, Zhe, et al.
Publicado: (2023)

Detection of ATRX and IDH1-R132H immunohistochemistry in the progression of 211 paired gliomas
por: Cai, Jinquan, et al.
Publicado: (2016)

A novel DNA repair‐related nomogram predicts survival in low‐grade gliomas
por: Li, Guanzhang, et al.
Publicado: (2020)

Uronic acid metabolic process–related gene expression–based signature predicts overall survival of glioma
por: Feng, Yuemei, et al.
Publicado: (2021)

Radiogenomics of lower-grade gliomas: a radiomic signature as a biological surrogate for survival prediction
por: Qian, Zenghui, et al.
Publicado: (2018)

Expression profile analysis of antisense long non-coding RNA identifies WDFY3-AS2 as a prognostic biomarker in diffuse glioma
por: Wu, Fan, et al.
Publicado: (2018)

Isocitrate dehydrogenase 1 (IDH1) mutation-specific microRNA signature predicts favorable prognosis in glioblastoma patients with IDH1 wild type
por: Wang, Zheng, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_2641m8liem3ikn4b9fqmkdqjk9